EUVIMEDEUVIMED entdecken
Crossref

Long-term implantable ventricular assist device support in children

Junsang Cho, Hari P Tunuguntla, Sebastian C Tume, Joseph A Spinner, Claire E Bocchini, Jun Teruya, Jeffrey S Heinle, Edward J Hickey, Iki Adachi

The Journal of Thoracic and Cardiovascular Surgery · 2024-04 · 167 (4) · 1417-1426.e1

DOI: 10.1016/j.jtcvs.2023.10.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024-04. Verfasst von Junsang Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices, Heart Transplantation, Heart Defects, Congenital. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In pediatrics, implantable continuous-flow ventricular assist devices (IC-VAD) are often used as a "temporary" support, bridging children to cardiac transplantation during the same hospital admission. METHODS: We conducted a retrospective review of our consecutive patients undergoing IC-VAD support at a tertiary pediatric heart center between 2008 and 2022. RESULTS: We identified 100 IC-VAD implant encounters: HeartWare HVAD (67; 67%), HeartMate II (17; 17%), and HeartMate 3 (16; 16%). The median (range) age, weight, and body surface area at implantation were 14.1 (3.0-56.5) years, 54.8 (13.3-140) kg, and 1.6 (0.6-2.6) m2, respectively. Cardiomyopathy (58; 58%) was the most common etiology, followed by congenital heart disease (37; 37%, including 13 single ventricle). At 6 months of IC-VAD support, 94 (94%) encounters achieved positive outcomes: ongoing support (59; 59%), transplant (33; 33%), and cardiac recovery (2; 2%). Eighty-two encounters (82%) resulted in home discharge with ongoing VAD support, including 38 (46%, out of 82) requiring readmission and 7 (9%, out of 82) resulting in death. There was a clinically significant decrease in morbidity rates before versus after home discharge: bleeding (1.55 vs 0.06), infection (0.84 vs 0.37), and stroke (0.84 vs 0.15 event per patient-year). Overall, 86 encounters (86%) reached positive end points at the latest follow-up (64 transplant, 15 ongoing support, and 7 recovery). Infection (29%; 4 of 14) was the most common cause of negative outcomes, followed by cerebrovascular accident (21%; 3), and unresolved frailty (21%; 3). The estimated overall survival at 1, 2, and 5 years was 90%, 86%, and 77%, respectively. CONCLUSIONS: This study suggests the feasibility of outpatient management of pediatric IC-VAD support. The ability to offer true long-term support maximizes the potential of IC-VAD support, not limited to a temporary bridging tool for heart transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHeart-Assist DevicesHeart TransplantationHeart Defects, CongenitalStrokeChildHumansAdolescentYoung AdultAdultMiddle AgedTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

congenital heart diseasemechanical circulatory supportpediatric heart failureventricular assist device

Autor:innen und Institutionen

  • Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.
  • Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.
  • Pediatric Critical Care, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.
  • Pediatric Infectious Disease, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.
  • Pathology & Immunology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.
  • Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex. Electronic address: iadachi@bcm.edu.

Zitieren

APA

Cho, J., Tunuguntla, H. P., Tume, S. C., Spinner, J. A., Bocchini, C. E., Teruya, J., Heinle, J. S., Hickey, E. J., & Adachi, I. (2024). Long-term implantable ventricular assist device support in children. The Journal of Thoracic and Cardiovascular Surgery, 167(4), 1417-1426.e1. https://doi.org/10.1016/j.jtcvs.2023.10.048

Vancouver

Cho J, Tunuguntla HP, Tume SC, Spinner JA, Bocchini CE, Teruya J, et al. Long-term implantable ventricular assist device support in children. The Journal of Thoracic and Cardiovascular Surgery. 2024;167(4):1417-1426.e1. doi:10.1016/j.jtcvs.2023.10.048

BibTeX
@article{Cho2024,
  author = {Cho, Junsang and Tunuguntla, Hari P and Tume, Sebastian C and Spinner, Joseph A and Bocchini, Claire E and Teruya, Jun and Heinle, Jeffrey S and Hickey, Edward J and Adachi, Iki},
  title = {Long-term implantable ventricular assist device support in children},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  volume = {167},
  number = {4},
  pages = {1417--1426.e1},
  doi = {10.1016/j.jtcvs.2023.10.048}
}
Kostenlos starten →